SRTA Strata Critical Medical
Strata Critical Medical earnings company data as of 4:48 AM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 9 Nov | EPS | 0.01 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by SRTA's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $98K bought by 2 insiders
- $125K sold by 1 insider outside a trading plan
- $382K sold by 1 insider under 10b5-1 plans
-
Reginald Love DirectorSale$29K 5,091 shares at $5.75 3.4% of stakeTraded Aug 10 Filed Aug 13
-
Amir Cohen Chief Accounting OfficerPlanned sale$299K 50,875 shares at $5.89 25% of stakeTraded May 21–22 Filed May 26
-
Amir Cohen Chief Accounting OfficerPlanned sale$83K 14,306 shares at $5.79 6.6% of stakeTraded May 11 Filed May 13
-
William A. Heyburn CEOBuy$76K 17,000 shares at $4.47 +1.2% to stakeTraded Dec 9, 2025 Filed Dec 10, 2025
-
Andrew Lauck DirectorBuy$22K 5,000 shares at $4.37 +3.8% to stakeTraded Dec 5, 2025 Filed Dec 5, 2025
-
Reginald Love DirectorSale$48K 11,000 shares at $4.37 8.8% of stakeTraded Nov 20, 2025 Filed Nov 24, 2025
-
Reginald Love DirectorSale$47K 11,000 shares at $4.31 8.1% of stakeTraded Nov 19, 2025 Filed Nov 20, 2025
Also filed in the last 12 months, not counted as buying or selling: 30 share withholdings for taxes, 28 stock grants, 4 sales to cover taxes, and 2 option exercises.
SEC filings
Recent issuer filings from EDGAR, 11 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13D | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.